These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4742737)
1. Proteins from human cerebrospinal fluid: binding with nucleic acids. Kubinski H; Javid M Science; 1973 Oct; 182(4109):296-7. PubMed ID: 4742737 [TBL] [Abstract][Full Text] [Related]
2. [Enzyme activity of the cerebrospinal fluid in pathological processes of the central nervous system]. Gromashevskaia LL; Gebesh VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(7):991-1000. PubMed ID: 4332538 [No Abstract] [Full Text] [Related]
3. Guanosine 3'-5'-monophosphate in the CSF of neurological patients. Trabucchi M; Cerri C; Spano PF; Kumakura K Arch Neurol; 1977 Jan; 34(1):12-3. PubMed ID: 188401 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. Sørensen PS; Gjerris A; Hammer M J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):50-7. PubMed ID: 3973621 [TBL] [Abstract][Full Text] [Related]
5. Increased polyamine concentrations in the cerebrospinal fluid of patients with brain tumors. Marton LJ; Heby O; Wilson CB Int J Cancer; 1974 Dec; 14(6):731-5. PubMed ID: 4377003 [TBL] [Abstract][Full Text] [Related]
6. Isoelectric focusing of CSF proteins in neurological diseases. Kjellin KG; Vesterberg O J Neurol Sci; 1974 Oct; 23(2):199-213. PubMed ID: 4139243 [No Abstract] [Full Text] [Related]
8. [Electrophoretic study of cerebrospinal fluid proteins in 104 cases of neuraxis tumors]. Castaigne P; Lhermitte F; Schuller E; Perrin JJ; Delasnerie N Rev Neurol (Paris); 1972 Nov; 127(5):505-15. PubMed ID: 4129440 [No Abstract] [Full Text] [Related]
9. Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier. Pazzagli A; Arnetoli G; Pepeu I; Amaducci LA Neurology; 1970 Aug; 20(8):783-6. PubMed ID: 5465848 [No Abstract] [Full Text] [Related]
10. Electrophoretic analysis of cerebrospinal fluid proteins in patients with central nervous system mass lesions. Weber EL J Neurosurg; 1972 Jun; 36(6):679-86. PubMed ID: 4113024 [No Abstract] [Full Text] [Related]
11. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus. Kmieciak-Kolada K; Majchrzak H; Herman ZS J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):78-81. PubMed ID: 216782 [TBL] [Abstract][Full Text] [Related]
12. Non-obstructive hydrocephalus associated with intracranial schwannomas: hyperproteinorrhachia as an etiopathological factor? Bloch J; Vernet O; Aubé M; Villemure JG Acta Neurochir (Wien); 2003 Jan; 145(1):73-8. PubMed ID: 12545266 [TBL] [Abstract][Full Text] [Related]
13. The sterol test for the diagnosis of human brain tumors. Paoletti P; Vandenheuvel FA; Fumagalli R; Paoletti R Neurology; 1969 Feb; 19(2):190-7. PubMed ID: 5812613 [No Abstract] [Full Text] [Related]
14. Studies of cerebrospinal fluid dynamics with intrathecally administered radioiodinated human serum albumin (131-IHSA). Tator CH; Fleming JF; Sheppard RH; Turner VM Can Med Assoc J; 1967 Sep; 97(10):493-503. PubMed ID: 6071789 [No Abstract] [Full Text] [Related]
15. Quantification and regulation of the adipokines resistin and progranulin in human cerebrospinal fluid. Berghoff M; Hochberg A; Schmid A; Schlegel J; Karrasch T; Kaps M; Schäffler A Eur J Clin Invest; 2016 Jan; 46(1):15-26. PubMed ID: 26509463 [TBL] [Abstract][Full Text] [Related]
16. [Studies on arginase activity in the cerebrospinal fluid]. Szilágyi AK J Neurol Sci; 1973 Feb; 18(2):143-54. PubMed ID: 4690639 [No Abstract] [Full Text] [Related]
17. Absolute or relative values in csf electrophoresis? An evaluation of the gamma-globulins in multiple sclerosis and other neurological diseases. Ackermann HP; Rieder HP; Wüthrich R Eur Neurol; 1975; 13(2):131-43. PubMed ID: 49269 [TBL] [Abstract][Full Text] [Related]
18. Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit. Hunter R; Thomson T; Reynolds CM; Pitcher PM J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):249-51. PubMed ID: 4829529 [TBL] [Abstract][Full Text] [Related]
19. Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review. Laviv Y; Kasper BS; Kasper EM Neurosurg Rev; 2018 Oct; 41(4):957-968. PubMed ID: 28265819 [TBL] [Abstract][Full Text] [Related]
20. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus. Inagawa T; Ishikawa S; Uozumi T J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]